Ben Freeberg

Oncology Ventures, Managing Partner

Ben Freeberg is the Founder and Managing Partner of Oncology Ventures, a venture capital fund focused on investing in early-stage startups that improve cancer care through data and technology. Established in November 2022, Oncology Ventures aims to tackle the high costs and complexities associated with cancer treatment by supporting companies that enhance early detection and optimize treatment plans, rather than investing in drug development or medical devices.1 2

Background and Experience

Freeberg has a rich background in healthcare investment, having previously served as Vice President at Optum Ventures, where he was involved with significant healthcare technology investments. He was also the first employee at Alpha Partners, a growth equity firm, and held key roles at Thyme Care, a cancer care startup that raised substantial funding from notable investors.1 3 4

His personal experience as a cancer survivor, having been diagnosed with Stage 3a cancer, profoundly influences his approach to investing. Freeberg's journey through cancer treatment has shaped his understanding of the challenges faced by patients and startups in the oncology space. He emphasizes the importance of investing in solutions that reduce healthcare costs and improve patient outcomes.2 3

Oncology Ventures

Oncology Ventures recently closed its inaugural fund with $30 million in committed capital, attracting investments from prominent healthcare institutions. The fund focuses on startups that leverage data and technology to enhance cancer care, with a particular interest in areas such as early detection, care navigation, and survivorship support.2 3 4

Freeberg's leadership is characterized by a proactive investment strategy, with the firm already backing several startups addressing critical gaps in cancer care.3 4 His commitment to improving oncology outcomes is further supported by an advisory board that includes experts from various sectors of healthcare and venture capital.3 4

In summary, Ben Freeberg combines his professional expertise in venture capital with his personal experience as a cancer survivor to lead Oncology Ventures, focusing on innovative solutions that aim to transform cancer care.